215 related articles for article (PubMed ID: 14566336)
1. Adaptor protein 3-dependent microtubule-mediated movement of lytic granules to the immunological synapse.
Clark RH; Stinchcombe JC; Day A; Blott E; Booth S; Bossi G; Hamblin T; Davies EG; Griffiths GM
Nat Immunol; 2003 Nov; 4(11):1111-20. PubMed ID: 14566336
[TBL] [Abstract][Full Text] [Related]
2. Novel insights from adaptor protein 3 complex deficiency.
Badolato R; Parolini S
J Allergy Clin Immunol; 2007 Oct; 120(4):735-41; quiz 742-3. PubMed ID: 17931556
[TBL] [Abstract][Full Text] [Related]
3. Nonsense mutations in ADTB3A cause complete deficiency of the beta3A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2.
Huizing M; Scher CD; Strovel E; Fitzpatrick DL; Hartnell LM; Anikster Y; Gahl WA
Pediatr Res; 2002 Feb; 51(2):150-8. PubMed ID: 11809908
[TBL] [Abstract][Full Text] [Related]
4. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis.
Baetz K; Isaaz S; Griffiths GM
J Immunol; 1995 Jun; 154(11):6122-31. PubMed ID: 7751653
[TBL] [Abstract][Full Text] [Related]
5. Centrosome polarization delivers secretory granules to the immunological synapse.
Stinchcombe JC; Majorovits E; Bossi G; Fuller S; Griffiths GM
Nature; 2006 Sep; 443(7110):462-5. PubMed ID: 17006514
[TBL] [Abstract][Full Text] [Related]
6. Two patients with Hermansky Pudlak syndrome type 2 and novel mutations in AP3B1.
Wenham M; Grieve S; Cummins M; Jones ML; Booth S; Kilner R; Ancliff PJ; Griffiths GM; Mumford AD
Haematologica; 2010 Feb; 95(2):333-7. PubMed ID: 19679886
[TBL] [Abstract][Full Text] [Related]
7. The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin.
Nishibori M; Cham B; McNicol A; Shalev A; Jain N; Gerrard JM
J Clin Invest; 1993 Apr; 91(4):1775-82. PubMed ID: 7682577
[TBL] [Abstract][Full Text] [Related]
8. Impaired Lysosomal Integral Membrane Protein 2-dependent Peroxiredoxin 6 Delivery to Lamellar Bodies Accounts for Altered Alveolar Phospholipid Content in Adaptor Protein-3-deficient pearl Mice.
Kook S; Wang P; Young LR; Schwake M; Saftig P; Weng X; Meng Y; Neculai D; Marks MS; Gonzales L; Beers MF; Guttentag S
J Biol Chem; 2016 Apr; 291(16):8414-27. PubMed ID: 26907692
[TBL] [Abstract][Full Text] [Related]
9. Disruption of AP3B1 by a chromosome 5 inversion: a new disease mechanism in Hermansky-Pudlak syndrome type 2.
Jones ML; Murden SL; Brooks C; Maloney V; Manning RA; Gilmour KC; Bharadwaj V; de la Fuente J; Chakravorty S; Mumford AD
BMC Med Genet; 2013 Apr; 14():42. PubMed ID: 23557002
[TBL] [Abstract][Full Text] [Related]
10. Defective HIV-1 particle assembly in AP-3-deficient cells derived from patients with Hermansky-Pudlak syndrome type 2.
Liu L; Sutton J; Woodruff E; Villalta F; Spearman P; Dong X
J Virol; 2012 Oct; 86(20):11242-53. PubMed ID: 22875976
[TBL] [Abstract][Full Text] [Related]
11. Ru2 and Ru encode mouse orthologs of the genes mutated in human Hermansky-Pudlak syndrome types 5 and 6.
Zhang Q; Zhao B; Li W; Oiso N; Novak EK; Rusiniak ME; Gautam R; Chintala S; O'Brien EP; Zhang Y; Roe BA; Elliott RW; Eicher EM; Liang P; Kratz C; Legius E; Spritz RA; O'Sullivan TN; Copeland NG; Jenkins NA; Swank RT
Nat Genet; 2003 Feb; 33(2):145-53. PubMed ID: 12548288
[TBL] [Abstract][Full Text] [Related]
12. AP-3-dependent trafficking and disease: the first decade.
Dell'Angelica EC
Curr Opin Cell Biol; 2009 Aug; 21(4):552-9. PubMed ID: 19497727
[TBL] [Abstract][Full Text] [Related]
13. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway.
Isaaz S; Baetz K; Olsen K; Podack E; Griffiths GM
Eur J Immunol; 1995 Apr; 25(4):1071-9. PubMed ID: 7737276
[TBL] [Abstract][Full Text] [Related]
14. Novel mutation causing Hermansky-Pudlak Syndrome Type 2.
Chiang PW; Spector E; Thomas M; Frei-Jones M
Pediatr Blood Cancer; 2010 Dec; 55(7):1438. PubMed ID: 20981699
[No Abstract] [Full Text] [Related]
15. Intracellular transport of MHC class II and associated invariant chain in antigen presenting cells from AP-3-deficient mocha mice.
Sevilla LM; Richter SS; Miller J
Cell Immunol; 2001 Jun; 210(2):143-53. PubMed ID: 11520080
[TBL] [Abstract][Full Text] [Related]
16. Melanocytes derived from patients with Hermansky-Pudlak Syndrome types 1, 2, and 3 have distinct defects in cargo trafficking.
Richmond B; Huizing M; Knapp J; Koshoffer A; Zhao Y; Gahl WA; Boissy RE
J Invest Dermatol; 2005 Feb; 124(2):420-7. PubMed ID: 15675963
[TBL] [Abstract][Full Text] [Related]
17. Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function.
Wei ML
Pigment Cell Res; 2006 Feb; 19(1):19-42. PubMed ID: 16420244
[TBL] [Abstract][Full Text] [Related]
18. Novel AP3B1 compound heterozygous mutations in a Japanese patient with Hermansky-Pudlak syndrome type 2.
Nishikawa T; Okamura K; Moriyama M; Watanabe K; Ibusuki A; Sameshima S; Masamoto I; Yamazaki I; Tanita K; Kanekura T; Kanegane H; Suzuki T; Kawano Y
J Dermatol; 2020 Feb; 47(2):185-189. PubMed ID: 31820501
[TBL] [Abstract][Full Text] [Related]
19. A role for endobrevin/VAMP8 in CTL lytic granule exocytosis.
Loo LS; Hwang LA; Ong YM; Tay HS; Wang CC; Hong W
Eur J Immunol; 2009 Dec; 39(12):3520-8. PubMed ID: 19830729
[TBL] [Abstract][Full Text] [Related]
20. The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2.
Jessen B; Bode SF; Ammann S; Chakravorty S; Davies G; Diestelhorst J; Frei-Jones M; Gahl WA; Gochuico BR; Griese M; Griffiths G; Janka G; Klein C; Kögl T; Kurnik K; Lehmberg K; Maul-Pavicic A; Mumford AD; Pace D; Parvaneh N; Rezaei N; de Saint Basile G; Schmitt-Graeff A; Schwarz K; Karasu GT; Zieger B; Zur Stadt U; Aichele P; Ehl S
Blood; 2013 Apr; 121(15):2943-51. PubMed ID: 23403622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
